SL-327

製品コードS1066 バッチS106604

印刷

化学情報

Chemical Structure Synonyms N/A Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C16H12F3N3S
分子量 335.35 CAS No. 305350-87-2
Solubility (25°C)* 体外 DMSO 67 mg/mL (199.79 mM)
Water Insoluble
Ethanol Insoluble
体内 （毎回新しく調製した物を用意してください）
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/ 0.22 μM, no activity towards Erk1, MKK3, MKK4, c-JUN, PKC, PKA, or CamKII;capable of transport through the blood-brain barrier.
in vitro

SL327 is a structural homologue of the specific MKK1/2 inhibitor U0126 with IC50 of 0.18 μM and 0.22 μM for MEK1 and MEK2 respectively. SL327 has no effect on a variety of other kinases, including PKA, PKC, or CamKII. [1]
in vivo

SL327 (50 mg/kg) crosses the blood-brain barrierand and blocks fear conditioning by inhibiting MAPK/ERK phosphorylation. [2] SL327 (30 mg/kg) significantly impairs spatial learning in mice. [3] SL327 (50 mg/kg) blocks cocaine-induced properties. [4]

プロトコル(参考用のみ)

動物実験 動物モデル Fear conditioning experiments in male Spague-Dawley rats.
投薬量 10-100 mg/Kg
投与方法 i.p.

参考

  • https://pubmed.ncbi.nlm.nih.gov/10969080/
  • https://pubmed.ncbi.nlm.nih.gov/10196568/
  • http://www.ncbi.nlm.nih.gov/pubmed?term=10541468
  • https://pubmed.ncbi.nlm.nih.gov/11102476/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Eph-ephrin signaling couples endothelial cell sorting and arterial specification [ Nat Commun, 2024, 15(1):2539] PubMed: 38570531
The clinically relevant MEK inhibitor mirdametinib combined with D-cycloserine and prediction error disrupts fear memory in PTSD models [ Transl Psychiatry, 2024, 14(1):492] PubMed: 39695081
Inhibition of ERK1/2 or CRMP2 Disrupts Alcohol Memory Reconsolidation and Prevents Relapse in Rats [ Int J Mol Sci, 2024, 25(10)5478] PubMed: 38791516
Inhibition of ERK1/2 or CRMP2 Disrupts Alcohol Memory Reconsolidation and Prevents Relapse in Rats [ Int J Mol Sci, 2024, 25(10)5478] PubMed: 38791516
A functional spectrum of PROKR2 mutations identified in isolated hypogonadotropic hypogonadism [ Hum Mol Genet, 2023, 32(10):1722-1729] PubMed: 36694982
ERK1/2 inhibition disrupts alcohol memory reconsolidation and prevents relapse [ bioRxiv, 2023, 10.1101/2023.12.12.571297] PubMed: none
Incongruence between transcriptional and vascular pathophysiological cell states [ Nat Cardiovasc Res, 2023, 2:2023530-549] PubMed: 37745941
Incongruence between transcriptional and vascular pathophysiological cell states [ Nat Cardiovasc Res, 2023, 2:2023530-549] PubMed: 37745941
Paeoniflorin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling [ Metab Brain Dis, 2022, 37(4):1057-1070] PubMed: 35230626
Inhibition of ERK1/2 regulates cognitive function by decreasing expression levels of PSD-95 in the hippocampus of CIH rats [ Eur J Neurosci, 2022, 55(6):1471-1482] PubMed: 35243702

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。